SLN

Silence Therapeutics
SLN

Overview Fund Activity

29 hedge funds and large institutions have $110M invested in Silence Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.

Holders
29
Holders Change
+2
Holders Change %
+7.41%
% of All Funds
0.46%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
4
Increased
8
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AG
1
Artal Group
Luxembourg
$3.13M
2
UOC
2
UBS O'Connor
Illinois
$591K
3
LOAME
3
Lombard Odier Asset Management (Europe)
United Kingdom
$20.4M
4
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$20.7M
5
ACM
5
Aquilo Capital Management
California
$8.14M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$0
2
SG Americas Securities
2
SG Americas Securities
New York
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$451K
4
Axa
4
Axa
France
$3.2M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$2.17M
Name Holding Trade Value Shares
Change 		Shares
Change %
CSS
26
Cubist Systematic Strategies
Connecticut
$16.1K +$16.1K +2,600 New
Deutsche Bank
27
Deutsche Bank
Germany
$3.84K -$20.7K -3,333 -84%
Bank of America
28
Bank of America
North Carolina
$3.41K +$3.41K +550 New
SPIA
29
Steward Partners Investment Advisory
New York
$620 – – –
Adage Capital Partners
30
Adage Capital Partners
Massachusetts
– -$10.7M -700,000 Closed
SG Americas Securities
31
SG Americas Securities
New York
– -$1.34M -87,987 Closed
1
2